# A Rare Presentation of Prostate Cancer: Psoas Muscle Metastasis Without Bone Involvement

**Authors:** Mahtab Zangui, Aye M Thida, Leen Khoury, Imad Karam, Ramtin Moradi, Aastha Baral, Maksim Agaronov, Brown Jordonna

PMC · DOI: 10.7759/cureus.85127 · 2025-05-31

## TL;DR

A rare case of prostate cancer spreading to the psoas muscle without affecting bones is presented, highlighting the need for awareness of unusual metastatic patterns.

## Contribution

The paper presents a novel case of prostate cancer metastasis to the psoas muscle without bone involvement, emphasizing diagnostic challenges and treatment approaches.

## Key findings

- Prostate cancer metastasized to the psoas muscle without bone involvement, initially mistaken for rhabdomyosarcoma.
- The patient responded positively to anti-androgen therapy and chemotherapy, with no evidence of bone metastases.
- The case highlights the importance of considering rare metastatic sites in prostate cancer diagnosis and management.

## Abstract

Prostate cancer is one of the most common cancers worldwide. We present a unique case of metastatic prostate cancer manifesting initially with a psoas muscle mass causing abdominal and hip pain. Computed tomography (CT) imaging revealed a large mass within the left psoas muscle with prominent pelvic and retroperitoneal lymphadenopathy, initially concerning for rhabdomyosarcoma. However, a biopsy of the psoas mass confirmed metastatic prostate adenocarcinoma. Interestingly, a nuclear whole-body bone scan and spinal MRI were negative for bone involvement or other metastases. The patient was treated with anti-androgen therapy along with abiraterone and docetaxel and had a positive serologic and radiologic response. He was also offered radiation as per the phase III Prostate Cancer Consortium in Europe-1 (PEACE-1) trial. This case underscores the importance of recognizing atypical metastatic sites, such as skeletal muscle, in prostate cancer, as they can complicate initial diagnosis and delay management. Understanding the mechanisms of rare metastatic patterns and the diagnostic approaches required is crucial for improving outcomes in prostate cancer patients.

## Linked entities

- **Chemicals:** abiraterone (PubChem CID 132971), docetaxel (PubChem CID 148124)
- **Diseases:** prostate cancer (MONDO:0005159), rhabdomyosarcoma (MONDO:0005212)

## Full-text entities

- **Diseases:** abdominal and hip pain (MESH:D015746), prostate adenocarcinoma (MESH:D000230), Prostate Cancer (MESH:D011471), Psoas (MESH:D016659), Muscle Metastasis (MESH:D009362), rhabdomyosarcoma (MESH:D012208), lymphadenopathy (MESH:D008206), cancers (MESH:D009369)
- **Chemicals:** abiraterone (MESH:C089740)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12207938/full.md

---
Source: https://tomesphere.com/paper/PMC12207938